e-learning
resources
Vienna 2003
Tuesday 30.09.2003
Severe pulmonary infection and sepsis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inhibitory activity of azithromycin on pseudomonas aeruginosa in biofilms
L. Xu, J. Zhang, X. Du (Beijing, China)
Source:
Annual Congress 2003 - Severe pulmonary infection and sepsis
Session:
Severe pulmonary infection and sepsis
Session type:
Thematic Poster Session
Number:
2858
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Xu, J. Zhang, X. Du (Beijing, China). Inhibitory activity of azithromycin on pseudomonas aeruginosa in biofilms. Eur Respir J 2003; 22: Suppl. 45, 2858
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Effects of subinhibitory concentrations of antibiotics on the biofilm formation of pseudomonas aeruginosa
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011
Synergistic activity of colistin in combination with N-acetylcysteine against colistin-resistant Acinetobacter Baumannii grown in biofilms
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018
In vitro activity of colistin in combination with N-acetylcysteine against Pseudomonas aeruginosa
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018
Effects of erythromycin on Pseudomonas aeruginosa adherence to collagen and morphology in vitro
Source: Eur Respir J 2003; 21: 401-406
Year: 2003
Exploring the susceptibility of P. aeruginosa biofilms in human mucus towards tobramycin treatment
Source: International Congress 2017 – Cystic fibrosis: clinical issues
Year: 2017
Synergistic activity of N-acetylcysteine and colistin against Stenotrophomonas maltophilia
Source: International Congress 2017 – How can microbiology and translational research help physicians?
Year: 2017
Antimicrobial activity of N-acetylcysteine against Stenotrophomonas maltophilia and Burkholderia cepacia complex grown in planktonic phase and in biofilm
Source: International Congress 2017 – How can microbiology and translational research help physicians?
Year: 2017
Immunomodulatory properties of macrolide antibiotics in the treatment of bronchial sepsis involving
P. aeruginosa
Source: Eur Respir J 2004; 24: Suppl. 48, 639s
Year: 2004
Azithromycin protects bronchial epithelial integrity after
Pseudomonas aeruginosa
infection independent of bactericidal activity
Source: Annual Congress 2008 - Best of lung epithelial cells 2008
Year: 2008
Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018
Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae
Source: Eur Respir J 2006; 27: 1020-1025
Year: 2006
The impact of testosterone on Pseudomonas aeruginosa pathogenicity and antimicrobial susceptibility
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018
Efficacy of Pseudomonas aeruginosa eradication regimens in bronchiectasis
Source: Eur Respir J , 49 (4) 1600851; DOI: 10.1183/13993003.00851-2016
Year: 2017
CusS-cusR mediate carbapenem-resistant Klebsiella pneumoniae resistant to tigecycline.
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019
The effect of erythromycin on the chronic lower airway infection by pseudomonas aeruginosa
Source: Eur Respir J 2004; 24: Suppl. 48, 640s
Year: 2004
Pulmonary infections with pseudomonas aeruginosa
Source: Eur Respir J 2004; 24: Suppl. 48, 642s
Year: 2004
The efficacy of macrolides in the treatment of bronchiectasis colonised by
Ps aeruginosa
Source: Eur Respir J 2004; 24: Suppl. 48, 638s
Year: 2004
Pseudomonas aerugenosa sensitivity changes to antibiotics under the influence of dissolved ozone
Source: Annual Congress 2011 - Pseudomonas aeruginosa infection and non-cystic fibrosis bronchiectasis
Year: 2011
Highly concentrated aerosolized tobramycin in the treatment of patients with cystic fibrosis and
Pseudomonas aeruginosa
infection
Source: Eur Respir J 2005; 26: Suppl. 49, 620s
Year: 2005
Mechanisms of induction of neutrophil apoptosis by the pseudomonas aeruginosa exotoxin pyocyanin
Source: Eur Respir J 2004; 24: Suppl. 48, 107s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept